NCT06860594 2026-03-18Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled